Simple spacer could cut hospital visits for seniors with lung disease
NCT ID NCT07030881
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether adding a spacer device to standard triple inhaler therapy can reduce serious flare-ups in older adults (65+) with asthma or COPD who are at high risk. 380 participants will either use the spacer with their inhaler or stick with the inhaler alone. The goal is to see if the spacer improves drug delivery and lowers the chance of needing emergency care or hospitalization.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- valved spacer device used with triple inhaled therapy (ICS/LABA/LAMA)
- What this could lead to
- If it works, this could offer a simple, low-cost way to reduce serious flare-ups and hospital visits in older adults with asthma or COPD.
- What could go wrong
- This is an early-stage trial with only 380 participants, and the open-label design may introduce bias. The spacer may not significantly reduce exacerbations, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA COPD are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Anhui Chest Hospital
RECRUITINGHefei, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Beilun District Second People's Hospital
RECRUITINGNingbo, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Ningbo Medical Center Lihuili Hospital
RECRUITINGNingbo, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Ninghai County First Hospital
RECRUITINGNinghai, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Taizhou Central Hospital
NOT_YET_RECRUITINGTaizhou, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Taizhou Municipal Hospital
RECRUITINGTaizhou, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The First Affiliated Hospital of Ningbo University
RECRUITINGNingbo, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The Second Affiliated Hospital of Anhui Medical University
RECRUITINGHefei, Anhui, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The Second Affiliated Hospital of Harbin Medical University
RECRUITINGHarbin, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.